Gsa Capital Partners LLP Atossa Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 310,754 shares of ATOS stock, worth $251,710. This represents 0.02% of its overall portfolio holdings.
Number of Shares
310,754
Previous 51,029
508.98%
Holding current value
$251,710
Previous $42,000
540.48%
% of portfolio
0.02%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ATOS
# of Institutions
75Shares Held
26.8MCall Options Held
79.5KPut Options Held
98.8K-
Black Rock Inc. New York, NY9.2MShares$7.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$4.92 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.95MShares$2.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.67MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$1.25 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $103M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...